Absolute Bioavailability Study With Bexagliflozin

Summary

The purpose of this study is to determine the absolute bioavailability of bexagliflozin following a single oral dose co-administered with an intravenous dose.

Timeline

Start

2018-08-01

Primary completion

2018-09-16

Completion

2018-09-16

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision to not initiate study due to sufficient bioavailability information”

Drugs

Indications